Helicobacter Pylori Clinical Trials

9 recruiting

Helicobacter Pylori Trials at a Glance

50 actively recruiting trials for helicobacter pylori are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Phase 4 with 16 trials, with the heaviest enrollment activity in Shanghai, Taipei, and Xi'an. Lead sponsors running helicobacter pylori studies include Shanghai Jiao Tong University School of Medicine, National Taiwan University Hospital, and Fudan University.

Browse helicobacter pylori trials by phase

Treatments under study

About Helicobacter Pylori Clinical Trials

Looking for clinical trials for Helicobacter Pylori? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Helicobacter Pylori trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Helicobacter Pylori clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 50 trials

Recruiting
Not Applicable

Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Eradication

Helicobacter Pylori Infection
Peking University First Hospital70 enrolled1 locationNCT07439445
Recruiting
Not Applicable

Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori

Helicobacter Pylori
National Institute of Allergy and Infectious Diseases (NIAID)25 enrolled1 locationNCT06871579
Recruiting
Not Applicable

Tegoprazan-containing Sequential for H. Pylori

Helicobacter Pylori Infection
Seoul National University Bundang Hospital400 enrolled1 locationNCT06382493
Recruiting
Phase 4

Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication

Helicobacter Pylori InfectionDyspepsia
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh80 enrolled2 locationsNCT07537634
Recruiting
Phase 4

Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection

Helicobacter Pylori Infection
National Taiwan University Hospital450 enrolled1 locationNCT05332444
Recruiting
Phase 4

7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth Therapy

Helicobacter Pylori
The First Affiliated Hospital with Nanjing Medical University316 enrolled1 locationNCT07232095
Recruiting

Effect of PPIs on Stool DNA Test for H. Pylori

Helicobacter Pylori Infection
Shanghai Jiao Tong University School of Medicine25 enrolled1 locationNCT07516262
Recruiting

Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies

Stomach NeoplasmsGastric NeoplasmsHelicobacter Pylori
University Hospital Center of Martinique112 enrolled1 locationNCT04949737
Recruiting

Changes Associated With H. Pylori and Gastric Carcinogenesis

Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Weill Medical College of Cornell University120 enrolled1 locationNCT02164409
Recruiting
Not Applicable

H. Pylori Eradication With Argon Plasma During Endoscopy

Helicobacter Pylori InfectionHelicobacter PyloriHelicobacter Pylori Gastrointestinal Tract Infection
Christopher C. Thompson, MD, MSc20 enrolled1 locationNCT06529159
Recruiting

Prospective Gastric Cancer Screening Using Helicobacter Pylori High-Risk Single Nucleotide Polymorphism Detection

Gastric AdenocarcinomaHelicobacter Pylori
Fudan University15,000 enrolled1 locationNCT06943781
Recruiting
Not Applicable

Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy

Helicobacter Pylori Infection
Kaohsiung Medical University552 enrolled1 locationNCT07358130
Recruiting
Not Applicable

Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp Eradication

Helicobacter Pylori Eradication
Kaohsiung Medical University390 enrolled1 locationNCT06349486
Recruiting

P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

Helicobacter Pylori Infection
Yueyue Li1,730 enrolled1 locationNCT07285096
Recruiting
Not Applicable

A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile

Helicobacter Pylori Infection
Miguel O'Ryan Gallardo500 enrolled3 locationsNCT05926804
Recruiting

The GAstric Precancerous Conditions Study

Gastric CancerHelicobacter Pylori InfectionAtrophic Gastritis+1 more
Stanford University600 enrolled1 locationNCT04191551
Recruiting
Phase 4

Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

Gastric CancerHelicobacter Pylori InfectionGastritis+2 more
Yongquan Shi1,248 enrolled1 locationNCT07139366
Recruiting
Phase 3

Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection

Helicobacter Pylori Eradication Rate
Eighth Affiliated Hospital, Sun Yat-sen University477 enrolled4 locationsNCT06734260
Recruiting

Distribution Characteristics of Helicobacter Pylori

Early Gastric CancerHelicobacter Pylori
Jilin University231 enrolled1 locationNCT07253948
Recruiting
Not Applicable

Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease

Helicobacter Pylori InfectionPeptic Ulcer
Can Tho University of Medicine and Pharmacy80 enrolled1 locationNCT07260006